Bank of New York Mellon Corp Has $63.51 Million Holdings in Ryan Specialty Holdings Inc. (NYSE:RYAN)

Bank of New York Mellon Corp trimmed its stake in Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 4.4% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 859,702 shares of the company's stock after selling 39,163 shares during the period. Bank of New York Mellon Corp owned 0.33% of Ryan Specialty worth $63,506,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. raised its stake in shares of Ryan Specialty by 5.7% in the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after acquiring an additional 529,631 shares in the last quarter. Bessemer Group Inc. raised its stake in shares of Ryan Specialty by 2.5% in the 4th quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock valued at $210,651,000 after acquiring an additional 79,976 shares in the last quarter. Principal Financial Group Inc. raised its stake in shares of Ryan Specialty by 66.4% in the 1st quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company's stock valued at $225,404,000 after acquiring an additional 1,218,147 shares in the last quarter. Blair William & Co. IL raised its stake in shares of Ryan Specialty by 0.6% in the 4th quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock valued at $177,464,000 after acquiring an additional 16,540 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Ryan Specialty by 2.7% in the 4th quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock valued at $115,468,000 after acquiring an additional 46,960 shares in the last quarter. 84.82% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Wells Fargo & Company cut their price objective on Ryan Specialty from $65.00 to $63.00 and set an "equal weight" rating on the stock in a research note on Thursday. Keefe, Bruyette & Woods lowered their target price on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. TD Cowen assumed coverage on Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 target price on the stock. Barclays lowered their target price on Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a report on Monday, July 7th. Finally, Morgan Stanley raised their target price on Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $75.00.

Insiders Place Their Bets

In other news, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction on Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the sale, the executive vice president owned 1,117 shares in the company, valued at $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director David P. Bolger sold 5,000 shares of the business's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total value of $354,000.00. Following the sale, the director owned 71,467 shares of the company's stock, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their position. The disclosure for this sale can be found here. Insiders own 52.21% of the company's stock.

Ryan Specialty Price Performance

RYAN traded down $0.80 during trading on Friday, hitting $63.84. The company's stock had a trading volume of 601,707 shares, compared to its average volume of 922,527. The firm's 50 day moving average price is $68.08 and its two-hundred day moving average price is $68.11. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 3.45. Ryan Specialty Holdings Inc. has a 12 month low of $55.95 and a 12 month high of $77.16. The stock has a market capitalization of $16.75 billion, a price-to-earnings ratio of 187.77, a price-to-earnings-growth ratio of 1.72 and a beta of 0.66.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.39. The firm had revenue of $690.17 million during the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The business's revenue for the quarter was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.35 EPS. Sell-side analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were given a dividend of $0.12 per share. The ex-dividend date was Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.75%. Ryan Specialty's payout ratio is currently 141.18%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.